title: Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.
authors.affiliation: Centre for Haematology & Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.|MRC Clinical Sciences Centre, Hammersmith Hospital, Imperial College London, London, UK.
authors.forename: Amit
authors.initials: A
authors.lastname: Patel
authors.affiliation: Department of Haematology, The North West London Hospitals NHS Trust, London, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Ayto
authors.affiliation: Centre for Haematology & Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
authors.forename: Donald H
authors.initials: DH
authors.lastname: MacDonald
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate